Last $27.28 USD
Change Today +0.29 / 1.07%
Volume 108.6K
PMC On Other Exchanges
New York
As of 12:47 PM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

pharmerica corp (PMC) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/6/14 - $30.48
52 Week Low
08/27/13 - $11.84
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PHARMERICA CORP (PMC)

pharmerica corp (PMC) Related Bloomberg News

View More Bloomberg News

pharmerica corp (PMC) Related Businessweek News

No Related Businessweek News Found

pharmerica corp (PMC) Details

PharMerica Corporation operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. It purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. The company also provides hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs, as well as offers consultant pharmacist services and medical records services. It operates approximately 96 institutional, 12 specialty infusion, and 5 specialty oncology pharmacies in 45 states, as well as provides pharmacy management services to 83 hospitals. The company serves institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. PharMerica Corporation was founded in 2006 and is headquartered in Louisville, Kentucky.

4,700 Employees
Last Reported Date: 02/28/14

pharmerica corp (PMC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $837.7K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $192.2K
President of Amerita, Inc
Total Annual Compensation: $290.0K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $320.1K
Senior Vice President of Purchasing & Trade R...
Total Annual Compensation: $294.2K
Compensation as of Fiscal Year 2013.

pharmerica corp (PMC) Key Developments

PharMerica Seeks Acquisitions

Greg Weishar, Chief Executive Officer of PharMerica Corporation (NYSE:PMC), said, "We continue growing through accretive acquisitions that create further value for PharMerica shareholders"

PharMerica Corporation Reports Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2014; Revised Earnings Guidance for the Full Year 2014; Provides Earnings Guidance for the Second Quarter of 2014

PharMerica Corporation reported unaudited consolidated financial results for the first quarter ended March 31, 2014. Revenues for the first quarter of 2014 were $452.2 million compared with $439.8 million for the first quarter of 2013. The increase in revenue was primarily the result of the fourth quarter 2013 acquisitions and branded drug price inflation, and was partially offset by previously disclosed bed losses as of December 31, 2013. Adjusted EBITDA for the first quarter of 2014 was $29.7 million compared with $34.6 million in the first quarter of 2013. Net income for the first quarter of 2014 was $4.8 million, or $0.16 diluted earnings per share, compared with $10.5 million, or $0.35 diluted earnings per share, for the same period in 2013. Adjusted diluted earnings per share was $0.37 in 2014 compared with $0.46 in 2013, a decrease of 19.6%. Cash flows provided by operating activities for the first quarter of 2014 were $4.4 million compared with cash flows provided by operating activities of $47.5 million in the first quarter of 2013. The decrease in cash provided by operating activities is due to a reduction in net income, a planned change in the company's inventory purchasing strategies and a decrease in liabilities partially offset by a decrease in accounts receivable. Operating income was $10.3 million, compared to $20 million for the last year. Income before income taxes was $7.8 million, compared to $17.4 million for the last year. Purchase of equipment and leasehold improvements was $6 million, compared to $6.7 million for the last year. The company updated its full year 2014 guidance metrics. For the full year 2014, the company now expects revenue in the range of $1.70 billion to $1.75 billion from $1.67 billion to $1.72 billion. Adjusted diluted earnings per share in the range of $1.40 to $1.50 from $1.35 to $1.50. Adjusted EBITDA in the range of $117.5 million to $123.0 million from $115.0 million to $123.0 million. Regarding adjusted diluted earnings per share for the second quarter of 2014, the company is expecting the range to be $0.34 to $0.36 per share.

PharMerica Corporation to Report Q1, 2014 Results on May 01, 2014

PharMerica Corporation announced that they will report Q1, 2014 results at 9:00 AM, Eastern Standard Time on May 01, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PMC:US $27.28 USD +0.29

PMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Omnicare Inc $62.32 USD -0.18
SunLink Health Systems Inc $1.16 USD -0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation PMC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMERICA CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at